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Huntington’s disease (HD) is a genetic neurodegenerative disorder that is characterized
by neuronal cell death. Although medium spiny neurons in the striatum are
predominantly affected, other brain regions including the cerebral cortex also
degenerate. Previous structural imaging studies have reported decreases in cortical
thickness in HD. Here we aimed to further investigate changes in cortical tissue
composition in vivo in HD using standard clinical T1-weighted (T1W) and T2-weighted
(T2W) magnetic resonance images (MRIs). 326 subjects from the TRACK-HD dataset
representing healthy controls and four stages of HD progression were analyzed. The
intracortical T1W/T2W intensity was sampled in the middle depth of the cortex over 82
regions across the cortex. While these previously collected images were not optimized
for intracortical analysis, we found a significant increase in T1W/T2W intensity (p < 0.05
Bonferroni-Holm corrected) beginning with HD diagnosis. Increases in ratio intensity
were found in the insula, which then spread to ventrolateral frontal cortex, superior
temporal gyrus, medial temporal gyral pole, and cuneus with progression into the most
advanced HD group studied. Mirroring past histological reports, this increase in the ratio
image intensity may reflect disease-related increases in myelin and/or iron in the cortex.
These findings suggest that future imaging studies are warranted with imaging optimized
to more sensitively and specifically assess which features of cortical tissue composition
are abnormal in HD to better characterize disease progression.
Keywords: Huntington’s disease, MRI, cerebral cortex, myelin, neurodegeneration
Abbreviations: ACC, anterior cingulate cortex; CSF, cerebral spinal fluid; GM, gray matter; HD, Huntington’s Disease; HTT,
huntingtin; MRI, magnetic resonance imaging; ROI, region of interest; T1W, T1-weighted; T2W, T2-weighted; WM, white
matter.
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INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant
neurodegenerative disorder that is caused by a CAG repeat
expansion in the HTT gene (MacDonald et al., 1993). This repeat
expansion leads to disrupted signaling in cortico-striatal circuits,
followed by a loss of projection neurons in the striatum (Rangel-
Barajas and Rebec, 2016). The neuronal loss and disrupted
communication within the brain lead to the characteristic traits
of the disease: progressive motor dysfunction, cognitive decline,
and behavioral deterioration (Walker, 2007; Ross and Tabrizi,
2011). Given that symptomology extends beyond basic motor
dysfunction into mood and cognition, the cerebral cortex may be
implicated in the pathology of HD. In fact, postmortem studies
have suggested that neuronal losses are prevalent in the cortex
(Hedreen et al., 1991; Selemon et al., 2003; Kim et al., 2014;
Mehrabi et al., 2016) which warrants in vivo investigations in
patients.
Since HD is progressive, in vivo imaging methods are
invaluable for identifying disturbances in brain structure or
function over the course of the disease. MRI specifically has
shown alterations in the brains of HD patients. These findings
have primarily been structural in nature, with decreases in
volume reported in the striatum, thalamus, cortical GM, and
major subcortical WM tracts (Aylward et al., 1998; Thieben
et al., 2002; Rosas et al., 2003; Fennema-Notestine et al., 2004;
Tabrizi et al., 2009, 2011, 2012; Paulsen et al., 2010; Stoffers
et al., 2010). Previous reports of cortical thinning in HD suggest
that thinning begins in motor and visual regions of the cortex
and spreads to nearby cortices with HD advancement (Rosas
et al., 2002, 2008; Tabrizi et al., 2009). In terms of cerebral
tissue composition, MRI has revealed increases in iron levels
in the striatum in HD (Bartzokis et al., 1999, 2007) and most
recently, diffusion MRI and quantitative magnetization imaging
have suggested a breakdown of myelin in deep WM tracts in
HD (Bourbon-Teles et al., 2017). Additionally, diffusion tensor
imaging (DTI) and functional MRI (fMRI) have been used to
display changes in the HD brain. DTI has highlighted that
microstructural changes in WM increase with HD progression
(Rosas et al., 2006; Weaver et al., 2009), that WM microstructure
scores are correlated with motor measures (Dumas et al.,
2012a; Poudel et al., 2014, 2015), and that aberrant network
connectivity develops in the HD brain (Poudel et al., 2014).
A compensatory mechanism in the presymptomatic HD brain
has been revealed with fMRI studies, where several cortical and
subcortical areas have shown increased event-related activation
(Paulsen et al., 2004; Klöppel et al., 2015). However, it was shown
that cortical activation starts to decrease in symptomatic HD
patients (Domínguez et al., 2017). Taken together, MRI provides
a sensitive tool for investigating the progressive degeneration of
the HD brain.
Although the cortical thickness studies suggest cortical
involvement in HD, cortical thickness is a broad measure of
cortical pathology that is sensitive to a range of microstructural
features (Zatorre et al., 2012). This study aimed to investigate
HD progression in the cerebral cortex using intracortical T1W
and T2W MR signal intensity as a potential marker of changes in
cortical tissue composition. In the brain, T1 (Stüber et al., 2014)
and T2 (Desmond et al., 2016) are sensitive to myelin and iron
amounts and can be used to measure tissue water content (Neeb
et al., 2006). Previously, the T1W/T2W ratio has been used to
study the relationship between intracortical myelin levels and
aging (Grydeland et al., 2013; Shafee et al., 2015), the trait of
openness (Yasuno et al., 2017), performance stability (Grydeland
et al., 2013), and error processing (Grydeland et al., 2016). The
ratio of T1W and T2W images has a reduced sensitivity to bias
(Glasser and Van Essen, 2011), aiding in removal of much of
the bias artifacts arising from a multi-site study, which may
obscure subtle disease-related changes. While these ratio maps
have been suggested to map myelin across the cortex (Glasser and
Van Essen, 2011), they might not be entirely specific to myelin
(Arshad et al., 2017), especially in the presence of iron or cellular
density changes that may be present in HD. Thus, in the present
study we interpret the ratio image intensity as a general marker
of cortical composition changes in HD rather than being specific
for myelin changes.
This study utilizes previously collected MRIs from the
cross-sectional TRACK-HD study (Tabrizi et al., 2009), which
contains a large number of well-described subjects that were
imaged at high resolution with multiple MR contrasts including
the requisite T1W and T2W for our analysis. The dataset
represents disease stages across HD, starting before disease onset
to well after the disease has progressed, which permits the
characterization of cortical changes with HD advancement. The
neuroimaging portion of the TRACK-HD study (Tabrizi et al.,
2009) was optimized for gray/white matter contrast to investigate
gross structural brain changes. In doing so, they previously
revealed widespread decreases in thickness and volume of cortical
GM in HD brains. Thus, this study examines the utility of
mapping intracortical MRI signal using standard clinical T1W
and T2W images to further characterize HD.
MATERIALS AND METHODS
TRACK-HD imaging and participant recruitment information
has been detailed previously (Tabrizi et al., 2009). The main
points are summarized below.
Participants
Three hundred and sixty six subjects were recruited from four
imaging centers. Each center aimed to recruit a sample of
90 subjects with the following composition: 30 controls, 30
participants with premanifest HD, and 30 participants with early
HD. There were 366 images made available to us, with the
following distribution: 123 controls, 120 premanifest HD, and
123 early HD.
Premanifest subjects were excluded with a burden of
pathology score lower than 250, and had a total motor score
below 5 using the motor assessment of the United Huntington’s
Disease Rating Scale (UHDRS). Healthy control subjects were
age- and gender-matched to the combined HD and preHD
group. To help control for environmental factors, controls were
chosen from spouses or partners of preHD subjects, or were
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gene-negative siblings. This strict selection criterion aids in
associating reported changes with HD.
Huntington’s disease participants were further subdivided
for analysis. Premanifest HD subjects were split based on the
median time for the predicted years to diagnosis (Langbehn et al.,
2004) into those far from onset (PreHD-A) and closer to onset
(PreHD-B). Early HD subjects were split based on their score on
a total functional capacity scale (TFC) (Shoulson and Fahn, 1979)
into Stage 1 (HD1, TFC 11–13) and Stage 2 (HD2, TFC 7–10).
In total 40 subjects had data that was not technically suitable
for analysis: 19 subjects were excluded in primary stages of
processing due to inadequate intrasubject image registration
and 21 subjects were excluded in the analysis due to low
signal-to-noise ratios in the MRIs, or obvious gain differences
between the T1W and T2W images. Subjects were removed
if their mean cortical intensity was outside mean ± 1.5× the
standard deviation of the entire cohort, which would suggest
a gain difference between the T1W and T2W images. The
remaining 326 subjects used in the study are summarized in
Table 1.
Imaging
All images were collected on 3T whole body scanners from
two vendors (Siemens [S] and Phillips [P]). T1W images were
collected using a 3D MPRAGE acquisition with the following
parameters: TR = 2200 ms [S]/7.7 ms [P], TE = 2.2ms
[S]/3.5 ms [P], TI = 900ms [S]/950 ms [P], FA = 10◦ [S]/8◦
[P], FOV = 28 cm [S]/24 cm [P], matrix size 256 × 256
[S]/224 × 224 [P], 208 [S]/164[P] sagittal slices with 1 mm
thickness to cover the entire brain. T2W images were acquired
(SPACE sequence on Siemens scanners, VISTA on Phillips
scanners) with identical field of view, acquisition matrix, slice
thickness and the following timing parameters: TR = 3000 ms,
TE = 421 ms.
Processing
The aim of the image processing was to accurately segment
GM and WM tissue classes in each subject’s T1W MRI
and construct a middle-depth surface through the cortex for
visualizing intracortical MRI signals. The middle depth surface
of each subject was registered to a template to allow for group
comparisons using a ROI analysis (Supplementary Table S1).
The software used for image processing was: MATLAB
(vR2015a1), Elastix (Klein et al., 2010; Shamonin et al., 2013),
ITK-SNAP (version 3.42) (Yushkevich et al., 2006), MIPAV v7.4
software3 using the JIST v3.04, TOADS-CRUISE vR3c5, and CBS
High-Res Brain Processing Tools Version v3.06 plug-ins.
First, images were rigidly registered to begin the cortical
segmentation. Each subject’s T2W image was rigidly registered
to that subject’s T1W image using Elastix. The T1W image
was rigidly registered to the 1 mm ICBM-152 asymmetric
template7, and then the 6-parameter affine transform was applied
to the T2W image such that both images were co-registered in
ICBM-152 space.
Cerebral tissue segmentation was performed on the T1W
image using custom scripts in MATLAB. First a custom written
algorithm was applied to perform local intensity normalization
to the T1W image to aid in segmentation of the pial surface
where cortical signal is artificially reduced in some images
due to bias in radiofrequency transmit and receive fields
(B1+ and B1−). Briefly, a new image was created by sliding
a 3 × 3× 3 window across the original T1W image, with
the center voxel location in the new image taking on the
greatest intensity value in the original image. This image was
smoothed using a 10 mm 3D Gaussian kernel creating an
intensity field map. The original T1W image was divided by
this new image, creating an image where intensity is normalized
by nearby voxels. This image was used solely for image
segmentation and not for subsequent MRI signal analysis, since
meaningful changes in intracortical signal are also potentially
normalized.
Next the ICBM-152 template was registered to the subject
























Age (years) 46.1 (10.5) 40.6 (8.7) 39.6 (8.8) 40.1 (8.9) 47.1 (10.2) 50.9 (8.8) 48.6 (9.8)
Women 60 (54%) 30 (56%) 29 (57%) 59 (56%) 40 (59%) 19 (46%) 59 (54%)
Disease-Burden score N/A 259.8 (29.0) 335.4 (30.2) 296.6 (48.2) 357.8 (74.5) 397.2 (69.7) 372.7 (75.3)
Centers
Site #1 25 14 11 25 15 12 27
Site #2 29 14 16 30 19 11 30
Site #3 29 13 15 28 23 4 27
Site #4 29 13 9 21 11 14 25
Disease-burden score = Age × (CAG length – 35.5). Data values are mean (SD), or number (%).
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to a smoothed brain mask that had been created in ICBM-152
space. The transformed binary mask was multiplied with the
normalized T1W image to skull strip the image. The resolution
in the masked normalized image was doubled in all dimensions,
and then the image was sharpened to further increase the
intensity gradient at the pial surface. An intensity threshold was
applied to the skull stripped image that was derived using an
intensity histogram to calculate the threshold to remove CSF.
A morphological algorithm to remove small objects was applied
to remove dura mater. The new cerebrum mask was first eroded,
then dilated to further remove dura mater. Following this, the
cerebrum mask was down sampled back to the original image
dimensions. One final threshold operation was applied to remove
CSF that may have been added in during the dilation operation.
This threshold intensity value was the same as was calculated
earlier using the intensity histogram. All segmentations were
manually inspected and corrected to remove any remaining dura
mater or cerebellum using ITK-SNAP. Each subject’s group was
blinded to the investigator until after the completion of all image
processing.
The cerebrum segmentation was used to mask the locally
normalized T1W created earlier. The masked image was used
as the input to the FANTASM algorithm (Pham, 2001) in
MIPAV, which segmented the image into two tissue classes: WM
and GM. Following segmentation, labels for each tissue class
were split back into left and right hemispheres for subsequent
processing. A volume-preserving cortical depth model was used
to generate the middle depth intracortical surface (Waehnert
et al., 2014). Additionally, the ICBM-152 asymmetric atlas was
processed equivalently to each subject, with automatic GM and
WM segmentations that were manually inspected for accuracy,
and a middle depth surface generated using a volume-preserving
model. Each subject’s surface was registered to the middle
depth surface generated from the ICBM-152 atlas using a
multi-scale surface registration approach (Tardif et al., 2015).
Each hemisphere was registered separately to improve speed and
accuracy. Surfaces labeled with the T1W/T2W ratio intensity were
created using CBS-Tools.
As B1 maps were not collected at time of imaging to correct
inhomogeneities, an alternative approach was used to correct
image intensities for analysis. This bias correction methodology
is utilized in the preprocessing steps of the Human Connectome
Project pipeline, and forms from the inverted contrast between
the T1W and T2W images (Glasser et al., 2013). Bias field maps
were thus calculated and applied to each subject’s images using
FSL tools (Smith et al., 2004). Briefly, an initial estimate of the
bias field forms from the square root of the product of the
T1W and T2W images. The cortical mask that was generated in
earlier processing steps of this study was applied to the bias map
estimation and the resulting image was normalized to the mean
value of the map, which now only contains values for inside the
cerebrum. Smoothing was applied within the cortical mask, using
a Gaussian smoothing kernel with a standard deviation of 5 mm.
The resulting bias field was applied to both T1W and T2W images
by a division of the image by the bias field. Finally, a corrected
ratio image was generated by dividing the corrected T1W image
by the corrected T2W image.
Statistics
Cortical maps were generated using SurfStat8 in MATLAB, where
signal intensity values were smoothed along the surface using a
6 mm Gaussian kernel. The Mars Atlas (Auzias et al., 2016) was
used to parcellate the cortex into 82 ROIs for analysis with linear
regressions computed using R9.
Signal intensity as a function of age was investigated for
each ROI. As ncvTest in R reported non-equal error variance
in the linear model, weighted regression was instead used
for the analysis. The weight used was 1/standard deviation
of the signal intensity for each ROI, which in effect applies
a lower weighting to images with more artifacts such as
noise. The regression equation took the form: Signal ∼
Age + Study_site + Disease_group, where Study_site was a factor
with four levels corresponding to the location where the scans
were taken. This was used to account for differences in bias fields
and imaging methods at each site, and was validated by a lower
Akaike criterion compared to using the scanner manufacturer.
An age term was included because T1W/T2W signal intensity
has been shown to vary with age in humans (Grydeland et al.,
2013). Corrections for type-I errors were performed using the
Holm–Bonferroni method (Ludbrook, 1998) on the resulting
p-values calculated for each Disease_group, accounting for 82
ROIs.
RESULTS
T1W/T2W Ratio Image Signal
The group signal maps calculated on per-vertex basis are
displayed in Figure 1. This was computed to be the intercept
of the regression equation that included Age and Study_site
as regressors to the vertex signal from each subject. Following
from this, differences from each HD group relative to the
control group based on the T1W/T2W ratio image intensity are
presented in Figure 2 as was conducted using the Mars Atlas
cortical parcellation. The regression coefficients are presented
for each group to illustrate the difference relative to the
control population. This value represents the residual difference
in ratio signal after age and study site are regressed out
of the data. Though insignificant, there was a trend for a
decrease in T1W/T2W ratio in the medial precentral gyrus
and posterior cingulate cortex in the PreHD-A group. In other
cortical regions, ratio intensity predominately demonstrated
trends for increasing intensity relative to controls. This trend
for increasing intracortical T1W/T2W intensity was similar for
groups: PreHD-A, PreHD-B and HD Stage 1. The p-value maps
(Figure 2, middle; listed in Supplementary Table 1) illustrate
the spread of areas with increasing signal from the insula to
other brain regions with disease advancement, however, most of
these regions were statistically insignificant following multiple
comparison correction. In Stage 2, the furthest progression of the
disease included in this study, showed trends for increasing ratio
signal across the cortex. Significant regions were found in the
8http://www.math.mcgill.ca/keith/surfstat/
9https://www.r-project.org
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FIGURE 1 | Middle depth T1W/T2W ratio signal for each study group. The effects of age and imaging site on the ratio signal were regressed out on a per-vertex
basis for each subject before calculation of the average.
FIGURE 2 | T1W/T2W ratio changes in HD. Coefficients from the intracortical signal analysis are mapped onto the cortex (left), illustrating the difference in ratio signal
relative to controls with effects of age and imaging site regressed out of the signal. Uncorrected p-values generated for each group from the linear models are
mapped onto the cortex for each region to visualize trends in changing intracortical signal (middle). Changes in intracortical signal that are significant following
multiple comparison correction are found in HD Stage 1 and 2 (right).
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HD Stage 1 and 2 group relative to controls following multiple
comparison correction, and are shown in the right panel of
Figure 2. The ratio signal increased in a similar pattern bilaterally
within the following significant regions: insula, ventrolateral
frontal cortex, superior temporal gyrus, medial temporal gyral
pole, and cuneus.
DISCUSSION
In this study, we used T1W/T2W ratio images to map changes
in cortical composition across HD time points. The increase
found in HD could be reflecting increases in myelin and/or iron
amounts, as both of these are prominent features of cortical
composition that affect the MR signal (Fukunaga et al., 2010).
A MRI voxel reporting an increase in myelin could be the result
of overall increases in myelin sheaths, or an increased density of
myelin due to neuronal loss and/or shrinkage. Oligodendrocytes,
the myelin producing cells in the central nervous system, are
known to double in density in presymptomatic HD gene carriers
in the tail of the caudate nucleus, while other cell densities
are unchanged (Gómez-Tortosa et al., 2001). Neuronal densities
have been shown to decrease while oligodendrocyte density
increases after HD onset in the caudate (Myers et al., 1991). While
these findings are in subcortical GM, increased glial density
been reported in the GM of the cortex with HD onset as well
(Passani et al., 1997; Rajkowska et al., 1998; Selemon et al.,
2003). These histological findings suggest that the signal increase
could be reporting both an increase in myelin levels as well
as decreases in neuronal densities, resulting in higher myelin
proportions.
Additionally, the increase in ratio signal could be reporting
increased levels of cortical iron. It has previously been reported
that iron loaded in the ferritin protein increases in subcortical
GM in HD (Bartzokis et al., 1999, 2007), and found only after
HD onset (Dumas et al., 2012b). Ferritin iron has a strong
effect on decreasing T2W signal, but only a weak effect on
increasing T1W signal (Vymazal et al., 1995), where both of these
changes would lead to an increase in the ratio studied. While
there are conflicting MRI reports of cortical iron accumulation
(Rosas et al., 2012) and iron decreases (Sánchez-Castañeda et al.,
2014), both studies agree that iron concentrations become further
altered the longer the disease progresses, a finding replicated in
this current study. As histology work has reported increases in
glia in both subcortical and cortical GM, it is likely that the
increase in subcortical iron levels could be present in the cortex
as well. Disentangling iron and myelin contributions to signal
can be difficult, since oligodendrocytes are iron enriched cells
(Todorich et al., 2009), and combined MRI and histology work
has shown that there is considerable overlap in iron and myelin
distributions in the cortex (Stüber et al., 2014). However, it has
been shown that only in later stages of HD, ferritin accumulates in
the microglia of both the cortical and the striatal tissue (Simmons
et al., 2007). Thus the increase in ratio signal could be separate
from changes in myelin, and be reporting increased ferritin
levels in cortical microglia. This separation is worth further
investigation due to iron’s role in oxidative stress, metabolism,
and iron-dependent enzyme production, which may contribute
to symptomology.
Finally, the increased ratio signal could be due to changes
in cytoarchitecture of the cortex, such that there is less bulk
water content per imaging voxel. Histological studies have
shown that neuronal densities decrease in HD (Passani et al.,
1997; Rajkowska et al., 1998; Selemon et al., 2003). This
decrease in neuronal density and increase in glial density could
therefore decrease MR visible water as it has been highlighted
in the mammalian central nervous system that neurons have
a higher water percentage than glial cells (LoPachin et al.,
1991). However, Eickhoff et al. (2005), previously reported that
myelin content dominates the cortical signal over the underlying
cytoarchitecture, such that it is unlikely that the change in
signal in HD is due to changes in cytoarchitecture. To obtain a
better understanding regarding the underlying pathology using
neuroimaging, more specific MRI contrasts should be used, such
as magnetization transfer for investigating myelin (Helms et al.,
2008), quantitative susceptibility mapping for iron (Langkammer
et al., 2010) and diffusion imaging for exploring neurite density
(Calamante et al., 2017).
The regional variations in signal in this study differ from the
pattern of cortical pathology in previous reports from cortical
thickness studies (Rosas et al., 2002, 2008; Tabrizi et al., 2009). It
was not necessarily expected that these two analysis techniques
would present the same results as they are aimed at differing
biological mechanisms. Indeed, it has been shown that tissue
composition changes in HD independently of gross structural
changes (Dumas et al., 2012b). We did, however, see a trend for an
early decrease in signal in the motor regions of the medial cortex,
which overlaps with early cortical thinning reported in this region
(Rosas et al., 2002, 2008; Tabrizi et al., 2009). Many of the
significant regions found in Stage 2 HD overlap with a previous
statistical map depicting regions of cortical thinning correlating
with verbal fluency scores in HD (Rosas et al., 2008). Our
finding of the ventrolateral frontal cortex being predominately
affected in Stage 2 HD may have structural significance given
that this area projects to the caudate (Cummings, 1993), a
structure that exhibits rapid degeneration in HD. Ventrolateral
frontal cortex appears to be involved in working memory and
contextual retrieval (Owen, 1997; Chapados and Petrides, 2015),
which could be considered be among the executive functions HD
patients experience deterioration in (Walker, 2007).
In this study, it was found that the earliest significant
region with increased ratio signal following multiple-comparison
correction was the insula. Insular atrophy in HD has previously
been correlated with executive dysfunction (Peinemann et al.,
2005). Microglia activation in the insula has been shown to be
associated with neuronal loss in this area early in the disease (Tai
et al., 2007). Additionally degeneration of the insula, as well as
frontal-striatal circuits has been associated with apathy severity
scores in HD (Martínez-Horta et al., 2018). Taken together,
insular degeneration appears to be linked strongly with disease
symptomology, and future work may look to use the MRI signal
in the insula to track HD progression and symptom worsening.
A major limitation of this study is that motion may affect
the quality of the MRI image. Due to the retrospective nature
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of the study, we were unable to control for patient motion.
As HD is a movement disorder, it is possible that our results
could be confounded by increased subject movement correlating
with disease progression. However, care was taken with manual
inspection of images during the segmentation step to only include
images that appeared motion-free. Additionally, previous work
in HD supports the time points of our findings, with late onset
showing the greatest changes in tissue composition (Rosas et al.,
2012).
An additional limitation is that there remains a residual
bias field artifact in the ratio image after division, which could
not be analytically corrected without B1 maps. Differences in
radiofrequency coil geometries between different MRI vendors
and sites can mean that the T1W and T2W images have intensity
bias fields that differ between sites. The T1W/T2W ratio does well
at removing much of the receive field bias (B1−), but incomplete
canceling of transmit bias (B1+). While a correction method was
applied to aid in removing some of the residual bias (Glasser
et al., 2013), a proper analytical correction with a B1 map would
be preferred for accuracy. This inter-site difference was also
accounted for in the linear model, where a site term was included
to account for inter-site differences in signal that arise from bias
fields. Additionally, subjects were removed from analysis that
exhibited an obvious gain difference in either the T1W or T2W
image, which would scale the resulting ratio image. A T1W/T2W
calibration algorithm was previously proposed which would
scale the contrast in each image to muscle and eye intensity
(Ganzetti et al., 2014). However, the calibration algorithm was
deemed inappropriate to apply as changes in skeletal muscular
structure have been shown in HD (Zielonka et al., 2014), such
that calibrating to muscle in HD may also provide a confounding
factor.
CONCLUSION
In summary, it was found that HD progression induces
widespread changes in cortical tissue composition, which was
visible in a large number of subjects using standard anatomical
images. It would be valuable to explore cortical pathology in HD
using MRI methods that are more specific for features of cortical
tissue composition, to better determine whether iron, myelin or
both are responsible for this change in ratio signal. Additionally,
revisiting this study with imaging optimized for intracortical
contrast and MRI protocols that account for intensity biases
between imaging sites, may provide increased sensitivity for
detecting subtle cortical changes earlier in HD with MRI. With
increased sensitivity, it would also be valuable to correlate
changes in cortical composition with clinical and behavioral
variables as well as other MRI metrics such as DTI. Furthermore,
optimized imaging for cortical contrast may allow for detecting
HD related changes in smaller cohorts. If intracortical signal
mapping can track HD through more disease stages, it may
have the potential to be used as a biomarker to mark disease
progression in clinical trials.
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